Skip to main content

Cipla 030 50 mg Pill: red & white, capsule/oblong

The pill with imprint Cipla 030 50 mg (Red & White, Capsule/Oblong, 0mm) has been identified as Nilotinib 50 mg and is used for Chronic Myelogenous Leukemia. It belongs to the drug class BCR-ABL tyrosine kinase inhibitors and is not a controlled substance.

Images for Cipla 030 50 mg

Nilotinib 50 mg Cipla 030 50 mg

Nilotinib

Imprint
Cipla 030 50 mg
Strength
50 mg
Color
Red & White (red opaque cap and white opaque body)
Shape
Capsule/Oblong (hard gelatin capsule)
Availability
Prescription only
Drug Class
BCR-ABL tyrosine kinase inhibitors
Pregnancy Category
D - Positive evidence of risk
CSA Schedule
Not a controlled drug
Labeler / Supplier
Cipla USA, Inc.
Manufacturer
Genvion Corporation
National Drug Code (NDC)
69097-0030

Get help with Imprint Code FAQs.

See also:

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.